Paying Parties

PAYING PARTY DETAILS

Initial Investments campaign for PMCB

Emails Sent:	2
Estimated volume generated:	$0
Total Paid:	$2,000

E-MAILS SENT FOR THIS CAMPAIGN:

SORT:

PMCB Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015

Update Profile / Unsubscribe Our new pick is PMCB - Pharmacyte Biotech --------------------------------------------------------------------------------------------------------------- Good Morning Readers And Welcome New Subscribers! PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary ...read more

Promoter:

Prime Time Stocks

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$2,000	UNKNOWN
Max Profit: 1.32 %	Gain at close: Pending

PMCB Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015

Promoter:

Moving Pennies

Stocks covered:	Compensation:	Avg $ Volume for Period:
PMCB	$2,000	UNKNOWN
Max Profit: 1.32 %	Gain at close: Pending

Paying Parties

Initial Investments campaign for PMCB

E-MAILS SENT FOR THIS CAMPAIGN:

**PMCB** Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015

**PMCB** Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015

PMCB Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015

PMCB Is Our New Pick With FDA Orphan Drug Status! Mar 25, 2015